Redox is a healthcare data integration startup that has made a mark in the industry with a focus on interoperability. Founded in 2014 and headquartered in the United States, the company has positioned itself as the leader chosen by health systems, digital health companies, and payers. With a mission to solve healthcare data integration problems, Redox has successfully connected to more than 6,700 healthcare entities.
The startup recently attracted $45.00M Series D investment, the latest being on 24 February 2021. The investment came from prominent firms including RRE Ventures, Battery Ventures, .406 Ventures, Adams Street Partners, and Avemir Growth Capital.
Redox's ability to bridge the gap between various healthcare entities has undoubtedly captured the interest of investors, reflecting the confidence in the company's potential for growth. With a focus on data analytics, digital health, healthcare, and information technology, Redox is well-positioned to leverage its recent investment to further expand its reach and impact in the healthcare industry.